Book an open event
The postgraduate online event on the 17 June – 21 June 2024 is the perfect opportunity to find out more about your course of interest, speak with our academics, and discover the opportunities that further study has to offer.
Join us live to learn more about:
- Your chosen course: Speak to our friendly teaching staff about courses, module content and delivery methods
- Employment prospects: Understand work placement opportunities, industry connections, and course accreditations
- Support services: Get all the information you need about admissions, accommodation and student finance
- Life at Herts: Hear from our students about their postgrad student experience at Herts
MSc Cancer Immunotherapy with Advanced Research
Why choose Herts?
Teaching Excellence: You will be taught by Internationally renowned researchers who support with research projects in Cancer Immunotherapy.
Employment Prospects: Graduates work as research scientists, scientific officers, and senior managers for organisations including Roche, Merck, and Astra Zeneca.
Sector-led Course Content: Explore our research interests of the Bioscience Research Group covering topics such as Adoptive T cell therapy, tumour-associated macrophages, NK cells, and monoclonal antibodies in cancer therapy.
Professional Accreditations
Subject to validation, this course will be accredited by the Royal Society for Biology Accreditation.
About the course
The use of the immune system in cancer therapy is a prevailing ambition in the field. You’ll gain expert knowledge of the numerous ways cancers and the immune system interact so you can learn how cancer immunotherapies are developed. We’ll provide a thorough understanding of immune effector mechanisms and cancer biology. You’ll develop a range of personal skills through self-directed learning and our problem-based approach to teaching.
Alternatively, consider taking our other MSc Cancer Immunotherapy routes:
Why choose this course?
- 1st for Biosciences in the Postgraduate Taught Experience Survey (PTES, Advance HE, 2023)
- You’ll be taught by our expert staff and innovative speakers from the biopharmaceutical industry
- Our modern Science Building provides excellent facilities for laboratory experiments, including DNA and genomic analysis eg QPCR, protein and proteomic science (eg MALDI-ToF), cell culture and Enzyme-based assays, isolated tissue studies and immunohistochemistry
- When you graduate, you’ll be equipped to work in a broad range of fields including medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law
- We adopt a blended learning approach to teaching, focussing on problem-based scenarios so you can develop strong critical analysis skills. You’ll benefit from exposure to practical techniques and guaranteed laboratory-based research projects
- If successful, you will have the opportunity to undertake an extended 12-month research project
- Allied Health was ranked in the top 25% of UK universities for research impact (Research Excellence Framework, 2021).
What will I study?
You’ll benefit from the research interests of the Bioscience Research Group. These include studies of the tumour microenvironment and communication with infiltrating immune cells, the methods tumours employ to diminish the effectivity of immune effector mechanisms and how tumours communicate using extracellular vesicles with pre-metastatic sites. We’ll cover topics such as adoptive T cell therapy, tumour-associated macrophages, NK cells, monoclonal antibodies in cancer therapy, vaccines, microbial cancer therapies and immune checkpoint blockade.
Teaching will be delivered through lectures, tutorials and practical classes. You’ll immerse yourself in a research project which utilises problem-based and self-directed learning. You’ll explore case studies to gain a strong critical understanding. Through your research projects, carried out in our innovative Science Building and supervised by world-leading researchers, you’ll be trained in data collection, analysis and its interpretation. You’ll also benefit from expert external speakers from the biopharmaceutical industry.
Further course information
| Course fact sheets | |
|---|---|
| MSc Cancer Immunotherapy - Extended (Revised 2024) | Download |
| Programme specifications | |
|---|---|
| MSc Cancer Immunotherapy - Extended (Revised 2024) | Download |
| Additional information | |
|---|---|
Sandwich placement or study abroad year |
n/a |
Applications open to international and EU students |
Yes |